[Helicobacter pylori infection: what to do after first intent treatment failure?].

Rev Prat

Service d'hépatologie et de gastroentérologie, groupe hospitalier Henri-Mondor - Albert-Chenevier AP-HR, Université Paris 12 Val-de-Marne, 94010 Créteil, France.

Published: September 2008

First intent therapy of H. pylori infection is triple therapy combining PPI, amoxicillin and clarithromycin for 7 to 10 days. Due to the increasing rate of primary resistance to clarithromycin, expected eradication rates are below 70%. Consequently, treatment effect has to be systematically assessed by urea breath test: in case of failure, a second line triple therapy combining PPI, amoxicillin and metronidazole instead of clarithromycin for 14 days should be prescribed. Using this strategy, the global eradication rate after two lines of treatment is 90%. Rescue triple therapies combine PPI and amoxicillin with either levoloxacin or rifabutin for 10 days. Levofloxacin should be used first in order to prevent development of rifabutin resistance among mycobacteria. The increasing rate of quinolone resistance led to the proposal to perform culture with susceptibility testing prior to third line therapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ppi amoxicillin
12
pylori infection
8
triple therapy
8
therapy combining
8
combining ppi
8
clarithromycin days
8
increasing rate
8
[helicobacter pylori
4
infection intent
4
intent treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!